Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8732750 | Revista Brasileira de Reumatologia | 2017 | 6 Pages |
Abstract
Antiâtumor necrosis factor (antiâTNF) drugs are frequently preferred in the treatment of rheumatologic diseases and other inflammatory diseases. The development of myositis after using antiâTNF is a rare clinical condition. Here we aimed to report cases who developed myositis after using antiâTNF and review the current literature. We report two cases of rheumatoid arthritis (RA) and a case of ankylosing spondylitis (AS) developed idiopathic inflammatory myopathy following antiâTNF therapy. In conclusion, myositis could develop during antiâTNF therapy, so these patients should be evaluated carefully initially for myositis and should be closely monitored due to the potential for developing myositis in treatment process.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Orhan Zengin, Mustafa Erkut Onder, Samet Alkan, GezmiÅ Kimyon, Nergis Hüseynova, Zeynep Hanım Demir, Bünyamin Kısacık, Ahmet Mesut Onat,